[1]
“ASSESSMENT OF ADVERSE EFFECTS OF IMATINIB IN CHRONIC MYELOID LEUKEMIA PATIENTS AT CIVIL HOSPITAL OF KARACHI, PAKISTAN”, FMHR, vol. 3, no. 10, pp. 744–748, Dec. 2025, Accessed: Nov. 10, 2026. [Online]. Available: https://fmhr.net/index.php/fmhr/article/view/1793